000 | 01381 a2200421 4500 | ||
---|---|---|---|
005 | 20250510211042.0 | ||
264 | 0 | _c19781027 | |
008 | 197810s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(78)92217-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLamon, J M | |
245 | 0 | 0 |
_aPrevention of acute porphyric attacks by intravenous haematin. _h[electronic resource] |
260 |
_bLancet (London, England) _cSep 1978 |
||
300 |
_a492-4 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAminolevulinic Acid _xurine |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCircadian Rhythm _xdrug effects |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeme _xanalogs & derivatives |
650 | 0 | 4 |
_aHemin _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Parenteral |
650 | 0 | 4 | _aMenstruation |
650 | 0 | 4 |
_aPorphobilinogen _xurine |
650 | 0 | 4 |
_aPorphyrias _xphysiopathology |
650 | 0 | 4 |
_aPulse _xdrug effects |
650 | 0 | 4 | _aRemission, Spontaneous |
700 | 1 | _aFrykholm, B C | |
700 | 1 | _aBennett, M | |
700 | 1 | _aTschudy, D P | |
773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8088 _gp. 492-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(78)92217-1 _zAvailable from publisher's website |
999 |
_c77922 _d77922 |